Skip to main content
    N

    Natera Inc (NTRA)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $288.48
    -30.61 (-9.59%)

    Market Cap: $46.27B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Natera Inc (NTRA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Natera (NTRA) to earn -$1.54 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.01B. Of 23 analysts, 21 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 5 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 23 ratings average 1.91, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 91% of the ratings.

    RatingAnalystsShare
    Strong Buy417.4%
    Buy1773.9%
    Hold28.7%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    23

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 21.3%.

    Fiscal year ending Dec 31, 2026
    -$1.54
    EPS consensus, revenue $3.01B
    Fiscal year ending Dec 31, 2027
    -$0.34
    EPS consensus, revenue $3.65B
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$1.54-$1.78 to -$0.6314$3.01B$2.91B to $3.04B17
    Dec 31, 2027-$0.34-$1.67 to $0.5814$3.65B$3.41B to $3.86B19

    Quarterly Estimates

    The EPS consensus falls from -$0.13 for the quarter ending Dec 31, 2026 to -$0.23 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.13-$0.39 to $0.0523$790.47M$723.14M to $837.90M23
    Mar 31, 2027-$0.23-$0.42 to -$0.079$843.73M$774.80M to $883.80M14

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 4 upward and 8 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202625
    Quarter ending Mar 31, 202723

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.41.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.54-$1.46-$1.46-$1.38-$1.41N/A
    Fiscal year ending Dec 31, 2027-$0.34-$0.18-$0.17-$0.06-$0.11N/A
    Quarter ending Mar 31, 2027-$0.23-$0.23-$0.27-$0.27-$0.24N/A

    Frequently Asked Questions About NTRA

    What is the NTRA stock forecast?

    Consensus analyst estimates put Natera's EPS at -$1.54 for the fiscal year ending Dec 31, 2026, on revenue of $3.01B. The consensus rating from 23 analysts is Buy.

    How do analysts rate NTRA stock?

    Of 23 analysts covering Natera, 4 rate it Strong Buy, 17 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from NTRA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.54, with estimates from -$1.78 to -$0.63 from 14 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.34, with estimates from -$1.67 to $0.58 from 14 analysts.

    What revenue do analysts expect from Natera next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.01B, with estimates from $2.91B to $3.04B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.65B, with estimates from $3.41B to $3.86B.

    How many analysts cover NTRA?

    23 analysts rate Natera stock, and 14 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.